英文論文
- 2024
- 2023
- 2022
- 2021
- 2020
- 2019
- 2018
- 2017
- 2016
- 2015
- 2014
- 2013
- 2012
- 2011
- 2010
- 2009
- 2008
- 2007
- 2006
- 2005
- 2004
2014
Matsumoto T, Hasegawa S, Matsumoto S, Horimatsu T, Okoshi K, Yamada M, Kawada K, Sakai Y
Overcoming the challenges of primary tumor management in patients with metastatic colorectal cancer unresectable for cure and an asymptomatic primary tumor
Dis Colon Rectum 57(6):679-86:2014
Xue P, Kanai M, Mori Y, Nishimura T, Uza N, Kodama Y, Kawaguchi Y, Takaori K, Matsumoto S, Uemoto S
Neutrophil-to-lymphocyte ratio for predicting palliative chemotherapy outcomes in advanced pancreatic cancer patients
Cancer Med 3(2):406-415:2014
Toyoda M, Ajiki T, Fujiwara Y, Nagano H, Kobayashi S, Sakai D, Hatano E, Kanai M, Nakamori S, Miyamoto A, Tsuji A, Kaihara S, Ikoma H, Takemura S, Toyokawa H, Terajima H, Morita S, Ioka T.
Phase I study of adjuvant chemotherapy with gemcitabine plus cisplatin in patients with biliary tract cancer undergoing curative resection without major hepatectomy (KHBO10004)
Cancer Chemother Pharmacol. 2014 Jun;73(6):1295-1301.
Narita Y, Taniguchi H, Komori A, Nitta S, Yamaguchi K, Kondo C, Nomura M, Kadowaki S, Takahari D, Ura T, Andoh M, Muro K.
CA19-9 level as a prognostic and predictive factor of bevacizumab efficacy in metastatic colorectal cancer patients undergoing oxaliplatin-based chemotherapy.
Cancer Chemother Pharmacol. 2014 Feb;73(2):409-16.
Kobayashi S, Nagano H, Sakai D, Eguchi H, Hatano E, Kanai M, Seo S, Taura K, Fujiwara Y, Ajiki T, Takemurra S, Kubo S, Yanagimoto H, Toyokawa H, Tsuji A, Terajima H, Morita S, Ioka T.
Phase I study of adjuvant gemcitabine or S-1 in patients with biliary tract cancers undergoing major hepatectomy
Cancer Chemother Pharmacol 74:(4):669-709:2014.
Yoko Mashimo, Yasumasa Ezoe, Kosuke Ueda, Yoshinao Ozaki, Yusuke Amanuma, Ikuo Aoyama, Takahiro Horimatsu, Shuko Morita, Shinichi Miyamoto, Tomonori Yano, Koji Higashino, Tsutomu Chiba, Manabu Muto.
Salvage photodynamic therapy is an effective and safe treatment for patients with local failure after definitive chemoradiotherapy for esophageal squamous cell carcinoma.
Journal of Cancer Therapy (JCT) 5(7):647-656.2014.
Takeshi Setoyama, Shinichi Miyamoto, Takahiro Horimatsu, Shuko Morita, Yasumasa Ezoe, Manabu Muto, Go Watanabe, Eiji Tanaka, Tsutomu Chiba.
Multimodal endoscopic treatment for delayed severe esophageal stricturecaused by incomplete stent removal.
Dis Esophagus. 27(2):112-115.2014.
Shinya Yamada, Hisashi Doyama, Kenshi Yao, Noriya Uedo, Yasumasa Ezoe, Ichiro Oda, Kazuhiro Kaneko,Yoshiro Kawahara, Cshizu Yokoi, Yasushi Sugiura, Hideki Ishikawa, Yoji Takeuchi, Yutaka Saito, Manabu Muto.
An efficient diagnostic strategy for small, depressed early gastric cancer with magnifying narrow-band imaging: a post-hoc analysis of a prospective randomized controlled trial.
Gastrointest Endosc. 2014 Jan;79(1):55-63.